Mergers and Acquisitions

Oncology company agrees to acquire NewBiotics, provides pipeline update

Published in Cancer Weekly, July 6th, 2004

Celmed BioSciences, Inc., announced that it has agreed to acquire NewBiotics, Inc., of San Diego, California, and provided a product pipeline update.

This transaction will broaden Celmed's technology base, diversify its product pipeline in the oncology sector and add key shareholders from the U.S., Europe, Canada and Asia.

"This acquisition is 'step one' on the path of Celmed's aggressive growth in the field of oncology," commented Andre de Villers, president and CEO of Celmed BioSciences.

"We have spent the past year restructuring our management team, refocusing our business priorities and accelerating the clinical development of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-07-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry